NDAINTRAVENOUSSOLUTION
Approved
Mar 2020
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
Started Feb 2021
50 enrolled
PTCL
Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma
Started Feb 2020
0Lymphoma, T-Cell
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
Started Sep 2018
11 enrolled
Lymphoma, T-Cell, Peripheral
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
Started Dec 2017
23 enrolled
Cutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma
Started Feb 2017
16 enrolled
Cutaneous T-cell Lymphoma (CTCL)